H-H M Yu1, Y-Y Tsai, S E Hoffe. 1. Department of Radiation Oncology, H. Lee Moffitt Cancer Center & Research Institute Tampa, FL 33612, USA. Michael.Yu@moffitt.org
Abstract
BACKGROUND: Bone metastases occur frequently in patients with advanced cancer and are a serious complication of cancer. The decision to treat is often individualized, based on each patient's clinical presentation, life expectancy, and quality of life. METHODS: We reviewed the current literature pertaining to management of metastatic disease to bone, and the medical, radiotherapeutic, and surgical treatment options for management of bone metastasis are discussed. RESULTS: Current management of skeletal metastasis includes analgesia, systemic therapy, radiation therapy, and surgery. We propose treatment algorithms for management of vertebral and nonvertebral bone metastases and suggest individualized interventions based on clinical presentation. CONCLUSIONS: Management of bone metastases is complex and requires a multidisciplinary approach. The goal of treatment is often palliative, and intervention and treatment regimens should be individualized based on the specific clinical presentation of each patient.
BACKGROUND:Bone metastases occur frequently in patients with advanced cancer and are a serious complication of cancer. The decision to treat is often individualized, based on each patient's clinical presentation, life expectancy, and quality of life. METHODS: We reviewed the current literature pertaining to management of metastatic disease to bone, and the medical, radiotherapeutic, and surgical treatment options for management of bone metastasis are discussed. RESULTS: Current management of skeletal metastasis includes analgesia, systemic therapy, radiation therapy, and surgery. We propose treatment algorithms for management of vertebral and nonvertebral bone metastases and suggest individualized interventions based on clinical presentation. CONCLUSIONS: Management of bone metastases is complex and requires a multidisciplinary approach. The goal of treatment is often palliative, and intervention and treatment regimens should be individualized based on the specific clinical presentation of each patient.
Authors: Prue Cormie; Daniel A Galvão; Nigel Spry; David Joseph; Dennis R Taaffe; Robert U Newton Journal: Support Care Cancer Date: 2014-01-15 Impact factor: 3.603
Authors: Luigi Zugaro; Mario DI Staso; Giovanni Luca Gravina; Pierluigi Bonfili; Lorenzo Gregori; Pietro Franzese; Francesco Marampon; Vincenzo Tombolini; Ernesto DI Cesare; Carlo Masciocchi Journal: Oncol Lett Date: 2016-01-14 Impact factor: 2.967
Authors: Michael J Seider; Stephanie L Pugh; Corey Langer; Gwen Wyatt; William Demas; Afshin Rashtian; Cathy L Clausen; Jerome David Derdel; Sean F Cleary; Christopher A Peters; Ashok Ramalingam; James E Clarkson; Michael Tomblyn; Rachel A Rabinovitch; Lisa A Kachnic; Lawrence B Berk Journal: Ann Nucl Med Date: 2018-08-09 Impact factor: 2.668